» Articles » PMID: 32104237

Effect of MiR-144-5p on the Proliferation, Migration, Invasion and Apoptosis of Human Umbilical Vein Endothelial Cells by Targeting RICTOR and Its Related Mechanisms

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2020 Feb 28
PMID 32104237
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of the present study was to investigate the effect of microRNA (miR)-144-5p on human umbilical vein endothelial cells (HUVECs) to explore the role of miR-144-5p in atherosclerosis. miR-144-5p expression was upregulated in HUVECs using miR-144-5p mimics. The relative expression level of miR-144-5p in HUVECs was detected using reverse transcription-quantitative PCR (RT-qPCR). Cell proliferation was detected by performing an MTT assay. Apoptosis was determined via flow cytometry. Cell migration ability was detected by a wound-healing assay. Cell invasion was determined by a transwell assay. The protein levels of phosphorylated (p)-PI3K, p-Akt and endothelial nitric oxide synthase (eNOS) were detected using western blot analysis. The binding sites between miR-144-5p and 3'-untranslated region of rapamycin-insensitive companion of mTOR (RICTOR) mRNA were predicted by TargetScan and confirmed by a dual luciferase reporter assay. The present study showed that miR-144-5p mimics significantly inhibited cell proliferation and induced apoptosis in HUVECs. In addition, miR-144-5p mimics could suppress migration and invasion of HUVECs. Further analysis identified that RICTOR was a direct target gene of miR-144-5p. Moreover, miR-144-5p upregulation decreased the protein level of p-PI3K, p-Akt and eNOS. In conclusion, miR-144-5p regulated HUVEC proliferation, migration, invasion, and apoptosis through affecting the PI3K-Akt-eNOS signaling pathway by altering the expression of RICTOR. These results indicated that miR-144-5p may be a potential target for the prevention and treatment of atherosclerosis.

Citing Articles

MiR-125b-5p ameliorates ox-LDL-induced vascular endothelial cell dysfunction by negatively regulating TNFSF4/TLR4/NF-κB signaling.

He W, Zhao L, Wang P, Ren M, Han Y BMC Biotechnol. 2025; 25(1):11.

PMID: 39856662 PMC: 11760099. DOI: 10.1186/s12896-025-00944-y.


Directional Endothelial Communication by Polarized Extracellular Vesicle Release.

Raju S, Botts S, Blaser M, Abdul-Samad M, Prajapati K, Khosraviani N Circ Res. 2024; 134(3):269-289.

PMID: 38174557 PMC: 10826926. DOI: 10.1161/CIRCRESAHA.123.322993.


Upgulation of lncRNA GASL1 inhibits atherosclerosis by regulating miR-106a/LKB1 axis.

Rui X, Wu X, Rong Z, Wang Z BMC Cardiovasc Disord. 2023; 23(1):11.

PMID: 36627571 PMC: 9832782. DOI: 10.1186/s12872-023-03038-9.


Relationships between Indicators of Lower Extremity Artery Disease and miRNA Expression in Peripheral Blood Mononuclear Cells.

Zalewski D, Ruszel K, Stepniewski A, Galkowski D, Feldo M, Kocki J J Clin Med. 2022; 11(6).

PMID: 35329950 PMC: 8948757. DOI: 10.3390/jcm11061619.


Ultrasound-targeted microbubble destruction-mediated miR-144-5p overexpression enhances the anti-tumor effect of paclitaxel on thyroid carcinoma by targeting STON2.

Chen X, Zhang X, Qian Y, Xia E, Wang Y, Zhou Q Cell Cycle. 2022; 21(10):1058-1076.

PMID: 35184686 PMC: 9037415. DOI: 10.1080/15384101.2022.2040778.


References
1.
Sun X, Belkin N, Feinberg M . Endothelial microRNAs and atherosclerosis. Curr Atheroscler Rep. 2013; 15(12):372. PMC: 3859467. DOI: 10.1007/s11883-013-0372-2. View

2.
Libby P, Hansson G . Inflammation and immunity in diseases of the arterial tree: players and layers. Circ Res. 2015; 116(2):307-11. PMC: 4299915. DOI: 10.1161/CIRCRESAHA.116.301313. View

3.
Heiss C, Rodriguez-Mateos A, Kelm M . Central role of eNOS in the maintenance of endothelial homeostasis. Antioxid Redox Signal. 2014; 22(14):1230-42. PMC: 4410282. DOI: 10.1089/ars.2014.6158. View

4.
Tabas I, Garcia-Cardena G, Owens G . Recent insights into the cellular biology of atherosclerosis. J Cell Biol. 2015; 209(1):13-22. PMC: 4395483. DOI: 10.1083/jcb.201412052. View

5.
Thum T, Mayr M . Review focus on the role of microRNA in cardiovascular biology and disease. Cardiovasc Res. 2012; 93(4):543-4. DOI: 10.1093/cvr/cvs085. View